| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
1,430,000,000 |
| Market
Cap: |
104.76(B) |
| Last
Volume: |
8,172,081 |
Avg
Vol: |
8,465,245 |
| 52
Week Range: |
$48.64 - $68.84 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 297 |
| Guru Rank Value : 4.1 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
86,763 |
367,796 |
891,893 |
1,852,495 |
| Total Sell Value |
$5,815,387 |
$21,391,604 |
$49,075,093 |
$90,475,166 |
| Total People Sold |
6 |
8 |
11 |
13 |
| Total Sell Transactions |
9 |
19 |
36 |
69 |
| End Date |
2024-01-25 |
2023-10-24 |
2023-04-25 |
2022-04-25 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Thepaut Eric Francis Yves |
SVP & Pres, Europe |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$31,552 |
D/D |
(1,867) |
98,323 |
|
- |
|
| Thepaut Eric Francis Yves |
SVP & Pres, Europe |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,485 |
100,190 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$30,217 |
D/D |
(1,788) |
133,646 |
|
- |
|
| Brennan Daniel J. |
EVP and CFO |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,499 |
135,434 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• – – |
2015-02-28 |
4 |
D |
$16.90 |
$62,817 |
D/D |
(3,717) |
37,144 |
|
- |
|
| Pierce David A |
SVP and President, Endoscopy |
• – – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,889 |
40,861 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$86,224 |
D/D |
(5,102) |
63,013 |
|
- |
|
| Ballinger Kevin J. |
SVP & Pres, Interven Cardio |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,337 |
68,115 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$35,913 |
D/D |
(2,125) |
134,534 |
|
- |
|
| Nanavaty Maulik |
SVP & Pres, Neuromodulation |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,652 |
136,659 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$403,927 |
D/D |
(23,901) |
1,254,583 |
|
- |
|
| Mahoney Michael F |
President & CEO |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,744 |
1,278,484 |
|
- |
|
| Sorenson John Bradley |
SVP, Glob Ops & Qual |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$48,588 |
D/D |
(2,875) |
15,306 |
|
- |
|
| Sorenson John Bradley |
SVP, Glob Ops & Qual |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,555 |
18,181 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$150,714 |
D/D |
(8,918) |
322,893 |
|
- |
|
| Pratt Timothy A. |
EVP, GC & Chief Admin Officer |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,931 |
331,811 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2015-02-28 |
4 |
D |
$16.90 |
$20,770 |
D/D |
(1,229) |
19,922 |
|
- |
|
| Prange Karen |
SVP&Pres, Uro & Womens Health |
• • – |
2015-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,721 |
21,151 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-02-27 |
4 |
D |
$16.90 |
$13,571 |
D/D |
(803) |
85,502 |
|
- |
|
| Mirviss Jeffrey B. |
SVP&Pres, Periph Intervent |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,389 |
86,305 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2015-02-27 |
4 |
D |
$16.90 |
$25,350 |
D/D |
(1,500) |
39,188 |
|
- |
|
| Carruthers Wendy |
SVP, Human Resources |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,618 |
40,688 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-27 |
4 |
D |
$16.90 |
$69,729 |
D/D |
(4,126) |
175,693 |
|
- |
|
| Dawkins Keith D |
EVP, Global Chief Med. Off. |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,758 |
179,819 |
|
- |
|
| Bose Supratim |
EVP & President, Asia-Pacific |
• • – |
2015-02-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,185 |
109,629 |
|
- |
|
2009 Records found
|
|
Page 2 of 81 |
|
|
0.35 (0.48%) 
